Endothelial cell thromboxane production and its inhibition by a calcium-channel blocker
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 49 (6), 916-919
- https://doi.org/10.1016/0003-4975(90)90865-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.JCI Insight, 1981
- Localisation and stimulation of prostacyclin production in vascular cellsNature, 1978
- Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endotheliumThrombosis Research, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976
- Synthesis of platelet-aggregating factor by human platelet microsomesBiochemical and Biophysical Research Communications, 1976
- Human vascular endothelial cells in culture *1Lack of response to serum growth factorsExperimental Cell Research, 1976
- Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial CellsJCI Insight, 1973